Intimation of Schedule of Analyst/ Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

10th August, 2026 BSE Limited National Stock Exchange of India Limited P.J. Towers, Dalal Street, Fort, Exchange Plaza, Bandra-Kurla Complex, Bandra Mumbai- 400 001 (East), Mumbai – 400 051 BSE scrip code: 543635 NSE symbol: PPLPHARMA Sub: Intimation of Schedule of Analyst/ Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Dear Sir / Madam, We wish to inform you that pursuant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the schedule of Analyst/Institutional Investor Meetings with the Company is as under: Date Name of Analyst/Investor Nature of Meeting Mode Venue Meet 2nd September, Ashwamedh - Elara India Mumbai 2026 Dialogue 2026 17th September, Jefferies 5th India Forum Gurgaon Group / One-on-one 2026 Meeting (Investor Physical 18th September, Kotak Healthcare Forum Mumbai Conference) 2026 23rd and 24th Goldman Sachs Global Singapore September, Healthcare CDMO Day 2026 Note: Dates are subject to changes. Changes may happen due to exigencies on the part of Investors / Company. Kindly take the above on record. Thank you. Yours truly, For Piramal Pharma Limited Maneesh Sharma Company Secretary & Compliance Officer Piramal Pharma Limited CIN: L24297MH2020PLC338592 Registered Office: Ananta Building, Piramal Corporate Park, Opp. Fire Brigade, Kamani Junction, LBS Marg, Kurla (West), Mumbai – 400070, Maharashtra, India Tel No. +91 22 3802 3000 / 4000; Email Id: shareholders.ppl@piramal.com www.piramalpharma.com